Regenesome is a biotechnology company that specializes in developing anti-aging technology to solve the problems of aging.
Regenesome has raised $135K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2025.
Regenesome's investors include Leave a Nest Capital, Japan System Techniques.
Regenesome is headquartered in Tokyo, Japan.
Regenesome is a biotechnology company that specializes in developing anti-aging technology to solve the problems of aging.
Regenesome is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Regenesome — Funding & Investors." VCBacked, September 18, 2025, https://www.vcbacked.co/company/regenesome. Accessed August 22, 2026.
VCBacked. (2025). Regenesome — Funding & Investors. Retrieved August 22, 2026, from https://www.vcbacked.co/company/regenesome
{{cite web |title=Regenesome — Funding & Investors |url=https://www.vcbacked.co/company/regenesome |website=VCBacked |access-date=August 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated